Ole Henrik Bang-Andreasen

Ole Henrik Bang-Andreasen is a Principal at AVANT BIO based in London, UK. In this capacity, he leads investment research, strategy, and European relations for the firm's $100 million Life Science Industrials fund, which targets early-stage and growth equity opportunities across North America and Europe. He currently serves on the boards of directors for several biotechnology and healthcare companies, including PathPresenter, PL BioScience, Wasteless Bio, and HC Andersen Capital, while also acting as Chairman of Portunus Solutions. Prior to his current position, he worked in the United States and Europe as a sell-side analyst and long/short public healthcare investment analyst after earning a Bachelor of Science in Accounting and Finance from Northeastern University and a Master of Science in Econometrics from Boston University. His current investment focus remains centered on early-stage life sciences technologies, diagnostics, and biopharma manufacturing tools.